INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹99 Cr | ₹236 Cr | ₹286 Cr | ₹326 Cr | ₹218 Cr |
What is the latest Operating Profit of INDOCO REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹99 Cr |
| Mar2024 | ₹236 Cr |
| Mar2023 | ₹286 Cr |
| Mar2022 | ₹326 Cr |
| Mar2021 | ₹218 Cr |
How is Operating Profit of INDOCO REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹99 Cr | -58.02 | |
| Mar2024 | ₹236 Cr | -17.35 | |
| Mar2023 | ₹286 Cr | -12.32 | |
| Mar2022 | ₹326 Cr | 49.43 | |
| Mar2021 | ₹218 Cr | - | |
Compare Operating Profit of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,257.2 Cr | 4.4% | 16.8% | -17.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | 4.4% |
16.8% |
-17.4% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses